These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8641494)

  • 21. Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH).
    Chen QJ; Sun XX; Li L; Gao XH; Wu Y; Gemzell-Danielsson K; Cheng LN
    Acta Obstet Gynecol Scand; 2007; 86(7):849-54. PubMed ID: 17611831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
    Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GnRH antagonists followed by a decline in serum estradiol results in adverse outcomes in donor oocyte cycles.
    Lindheim SR; Morales AJ
    Hum Reprod; 2003 Oct; 18(10):2048-51. PubMed ID: 14507819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization.
    Surrey ES; Bower J; Hill DM; Ramsey J; Surrey MW
    Fertil Steril; 1998 Mar; 69(3):419-24. PubMed ID: 9531870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
    Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
    Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Embryo implantation after human in vitro fertilization: importance of endometrial receptivity.
    Paulson RJ; Sauer MV; Lobo RA
    Fertil Steril; 1990 May; 53(5):870-4. PubMed ID: 2110078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization-embryo transfer cycles.
    Lindheim SR; Cohen MA; Chang PL; Sauer MV
    J Assist Reprod Genet; 1999 May; 16(5):242-6. PubMed ID: 10335470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three hundred cycles of oocyte donation at the University of Southern California: assessing the effect of age and infertility diagnosis on pregnancy and implantation rates.
    Sauer MV; Paulson RJ; Ary BA; Lobo RA
    J Assist Reprod Genet; 1994 Feb; 11(2):92-6. PubMed ID: 7819708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of bushen tiaojing recipe on the quality of the oocytes and reproductive hormones in the follicular fluid in IVF-ET patients].
    Liang Y; Du HL; Chang XF; Zhao SN; Lei LM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Aug; 34(8):911-6. PubMed ID: 25223171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The appearance of one-pronuclear human oocytes is associated with a better ovulation-induction response and successful pregnancy outcome.
    Jackson KV; Nureddin A; Clarke RN; Hornstein MD; Rein MS; Friedman AJ
    Fertil Steril; 1992 Aug; 58(2):366-72. PubMed ID: 1633904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist.
    Younis JS; Matilsky M; Radin O; Ben-Ami M
    Fertil Steril; 2001 Aug; 76(2):294-9. PubMed ID: 11476775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High progesterone levels adversely affect embryo quality and pregnancy rates in in vitro fertilization and oocyte donation programs.
    Yovel I; Yaron Y; Amit A; Peyser MR; David MP; Kogosowski A; Lessing JB
    Fertil Steril; 1995 Jul; 64(1):128-31. PubMed ID: 7789547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a "freeze all" strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg.
    Zhu X; Ye H; Fu Y
    Fertil Steril; 2017 Feb; 107(2):379-386.e4. PubMed ID: 27865446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization.
    Orvieto R; Zohav E; Scharf S; Rabinson J; Meltcer S; Anteby EY; Homburg R
    Gynecol Endocrinol; 2007 Feb; 23(2):72-5. PubMed ID: 17454155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study.
    European Recombinant LH Study Group
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2607-18. PubMed ID: 11397861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased progesterone/estradiol ratio on the day of HCG administration adversely affects success of in vitro fertilization-embryo transfer in patients stimulated with gonadotropin-releasing hormone agonist and recombinant follicle-stimulating hormone.
    Ou YC; Lan KC; Chang SY; Kung FT; Huang FJ
    Taiwan J Obstet Gynecol; 2008 Jun; 47(2):168-74. PubMed ID: 18603501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of supraphysiologic estradiol levels on human nidation.
    Gelety TJ; Buyalos RP
    J Assist Reprod Genet; 1995 Aug; 12(7):406-12. PubMed ID: 8574066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).
    Olivennes F; Belaisch-Allart J; Emperaire JC; Dechaud H; Alvarez S; Moreau L; Nicollet B; Zorn JR; Bouchard P; Frydman R
    Fertil Steril; 2000 Feb; 73(2):314-20. PubMed ID: 10685535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.